The editors.

Grey Peptides is edited by independent researchers and writers working with primary regulatory and scientific sources. The editorial voice aims for the register of a reference work rather than a marketing site or a clinical guideline.

Editorial standards

Every entry published on Grey Peptides meets the following standards before going live:

• At least one named, verifiable source. FDA prescribing information, EMA summary of product characteristics, PubMed-indexed peer-reviewed publication, ClinicalTrials.gov registry entry, or manufacturer regulatory filing.
• Honest evidence grading. Evidence levels (high / medium / low) reflect the actual strength of the underlying data, not marketing claims or community enthusiasm.
• Clear regulatory status. FDA-approved compounds, investigational compounds, discontinued compounds, research-only compounds, and not-approved-in-US compounds are each labeled distinctly.
• Non-peptides flagged. Small molecules and full proteins that enter community peptide discussion are included but flagged as such, so readers are not misled about the molecular class.
• Community dosing labeled as community dosing. Where no regulator-endorsed dose exists, we report what research-chemical and biohacker communities use — and say clearly that this is not clinical guidance.

Corrections

We take factual corrections seriously. If an entry misstates a mechanism, misattributes a finding, or cites an outdated source, please contact the editors. Corrections are made promptly and, where material, noted in the entry's metadata.

Independence

Grey Peptides does not sell peptides, accept vendor commissions, or publish compensated product reviews. Where affiliate links appear on the site, they are disclosed inline and do not affect editorial content.